Advertisement

Japanese chemical company Asahi Kasei Corporation has agreed to buy heart defibrillator maker Zoll Medical Corporation (NASDAQ: ZOLL) for $93 per share. This represents a premium of 23.8 percent ofver the Chelmsford, Mass-based medical device maker’s closing stock price on Friday. The deal, worth a total of $2.21 billion, has been approved by both companies’ boards and is expected to close in the second quarter.

SOURCE

Advertisement
Advertisement